Cargando…
Iterative and prolonged remission in metastatic breast cancer using pegylated irinotecan: a case report
INTRODUCTION: Pegylated irinotecan NKTR-102 is a topoisomerase I inhibitor-polymer conjugate. This new formulation of irinotecan has been evaluated in a phase II clinical trial and is showing remarkable activity. To the best of our knowledge, this is the first case report of an impressive iterative...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429498/ https://www.ncbi.nlm.nih.gov/pubmed/25971303 http://dx.doi.org/10.1186/1752-1947-9-5 |